| Q34007035 | A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t |
| Q47225954 | AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration. |
| Q35126780 | Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies |
| Q37734451 | Agents that bind annexin A2 suppress ocular neovascularization |
| Q33397385 | Alternate serotype adenovector provides long-term therapeutic gene expression in the eye. |
| Q36804949 | An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization |
| Q33582933 | Animal models of choroidal and retinal neovascularization |
| Q39455385 | Animal models of ocular angiogenesis: from development to pathologies |
| Q35024891 | Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A |
| Q34543206 | Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism |
| Q35753400 | Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization |
| Q28743307 | Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye |
| Q35745444 | Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization |
| Q33969496 | Cellular mechanisms of blood-retinal barrier dysfunction in macular edema |
| Q27312714 | Characterization of a spontaneous retinal neovascular mouse model |
| Q92069814 | Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction |
| Q33846832 | Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis |
| Q93703437 | Correspondence |
| Q34521256 | Deficiency of neuropilin 2 suppresses VEGF-induced retinal neovascularization |
| Q30631779 | Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor |
| Q45269945 | Ectopic norrin induces growth of ocular capillaries and restores normal retinal angiogenesis in Norrie disease mutant mice. |
| Q42113345 | Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor |
| Q37482353 | FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by alpha1(IV)NC1 |
| Q54977469 | Flt3 Regulation in the Mononuclear Phagocyte System Promotes Ocular Neovascularization. |
| Q34775400 | HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin |
| Q90095624 | Hypoxic drive caused type 3 neovascularization in a preclinical model of exudative age-related macular degeneration |
| Q50010764 | In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model |
| Q35747297 | Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment |
| Q30686422 | Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin |
| Q35191520 | Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF. |
| Q57144790 | Localized SDF-1α Delivery Increases Pro-Healing Bone Marrow-Derived Cells in the Supraspinatus Muscle Following Severe Rotator Cuff Injury |
| Q62066203 | Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model |
| Q34316044 | Macular telangiectasia type 2. |
| Q36296789 | Molecular pathogenesis of retinal and choroidal vascular diseases |
| Q52568540 | Mousetap, a Novel Technique to Collect Uncontaminated Vitreous or Aqueous and Expand Usefulness of Mouse Models. |
| Q33833925 | Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse |
| Q38074872 | Ocular neovascularization |
| Q40870038 | Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization |
| Q34000654 | Oxidative stress promotes ocular neovascularization. |
| Q33502718 | Perturbation of mouse retinal vascular morphogenesis by anthrax lethal toxin. |
| Q35745360 | Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathy |
| Q37734454 | Prolonged blockade of VEGF receptors does not damage retinal photoreceptors or ganglion cells |
| Q93000295 | Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment |
| Q64937118 | Retinal Vasculature in Development and Diseases. |
| Q35210888 | Retracted: Nuclear Factor Kappa-B Signaling Is Integral to Ocular Neovascularization in Ischemia-Independent Microenvironment |
| Q36781055 | Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/Akt/mTOR pathway |
| Q88518534 | Submacular hemorrhage and grape-like polyp clusters: factors associated with reactivation of the lesion in polypoidal choroidal vasculopathy |
| Q30560557 | Sustained delivery of a HIF-1 antagonist for ocular neovascularization |
| Q89531841 | Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles |
| Q35642213 | TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage |
| Q35005977 | TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis |
| Q34311551 | Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature |
| Q30495106 | The mouse retina as an angiogenesis model |
| Q36573796 | Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit |
| Q49334226 | Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage |
| Q42140561 | Use of recombinant angiostatin to prevent retinal neovascularization |
| Q55331083 | VEGF/VEGFR2 blockade does not cause retinal atrophy in AMD-relevant models. |